AMRXCommon stockNASDAQ
AMRX Common stock
This is the ticker-level security page. The issuer is Amneal Pharmaceuticals, Inc..
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$2.9B
Net income TTM
$48.9M
Total assets
$3.6B
Total debt
$2.6B
Total equity
-$109.5M
Profit margin
1.7%
ROE
Not available
ROA
1.4%
Latest issuer financial snapshot: 2024-12-31